Exencial Wealth Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-9,045
| Closed | -$291K | – | 453 |
|
|
2023
Q1 | $291K | Buy |
+9,045
| New | +$291K | 0.02% | 357 |
|
|
2022
Q4 | – | Sell |
-9,045
| Closed | -$244K | – | 437 |
|
|
2022
Q3 | $244K | Buy |
+9,045
| New | +$244K | 0.01% | 361 |
|
|
2021
Q4 | – | Sell |
-40,555
| Closed | -$1.13M | – | 473 |
|
|
2021
Q3 | $1.13M | Hold |
40,555
| – | – | 0.05% | 182 |
|
|
2021
Q2 | $1.2M | Hold |
40,555
| – | – | 0.07% | 218 |
|
|
2021
Q1 | $1.13M | Sell |
40,555
-1,075
| -3% | -$30.1K | 0.07% | 206 |
|
|
2020
Q4 | $1.18M | Buy |
41,630
+14,636
| +54% | +$415K | 0.08% | 183 |
|
|
2020
Q3 | $679K | Buy |
26,994
+200
| +0.7% | +$5.03K | 0.04% | 227 |
|
|
2020
Q2 | $654K | Buy |
26,794
+462
| +2% | +$11.3K | 0.06% | 202 |
|
|
2020
Q1 | $390K | Buy |
26,332
+100
| +0.4% | +$1.48K | 0.07% | 167 |
|
|
2019
Q4 | $426K | Buy |
26,232
+350
| +1% | +$5.68K | 0.07% | 183 |
|
|
2019
Q3 | $336K | Buy |
25,882
+15,532
| +150% | +$202K | 0.07% | 183 |
|
|
2019
Q2 | $134K | Hold |
10,350
| – | – | 0.03% | 224 |
|
|
2019
Q1 | $163K | Sell |
10,350
-2,500
| -19% | -$39.4K | 0.04% | 221 |
|
|
2018
Q4 | $259K | Hold |
12,850
| – | – | 0.07% | 182 |
|
|
2018
Q3 | $319K | Sell |
12,850
-2,894
| -18% | -$71.8K | 0.07% | 143 |
|
|
2018
Q2 | $432K | Buy |
15,744
+1,000
| +7% | +$27.4K | 0.12% | 122 |
|
|
2018
Q1 | $454K | Buy |
14,744
+1,100
| +8% | +$33.9K | 0.14% | 119 |
|
|
2017
Q4 | $488K | Buy |
+13,644
| New | +$488K | 0.15% | 116 |
|